生殖内分泌和不孕症奖学金网站是否反映了对多样性,公平性和包容性的承诺?
Jasmine Eliwa1, Patricia J Goedecke2, Jim Wan2
1Department of Obstetrics and Gynecology, University of Tennessee Health Sciences Center, Memphis, Tennessee.
F&S reports
|January 9, 2025
概括
生殖内分泌学和不孕不育学会网站显示多样性元素较低,没有项目显示高水平. 加强这些元素可以改善招聘代表性不足的研究员.
科学领域:
- 医学教育 医学教育
- 生殖内分泌学和不孕症 (REI)
- 多样性,公平性和包容性 (DEI)
背景情况:
- 奖学金计划网站对于吸引潜在的实习生至关重要.
- 在这些网站上评估多样性元素可以揭示机构对DEI的承诺.
- 了解目前的DEI代表是改善未来招聘策略的关键.
研究的目的:
- 在生殖内分泌和不孕症 (REI) 奖学金计划网站上量化多样性元素 (DE) 的存在.
- 分析这些DEs的频率与程序特征相关,例如地理区域和认证状态.
主要方法:
- 对49个REI奖学金网站进行了系统审查.
- 评估了与DEI相关的20个特定多样性元素 (DE).
- 网站被分类为低 (0-6 DEs),中度 (7-13 DEs) 或高 (14-20 DEs) 基于存在的DE数量.
- 使用R软件进行了统计分析,以检查DE与程序属性之间的关联.
主要成果:
- 大多数REI奖学金网站 (84%) 的多样性元素数量很少 (平均3个DE).
- 没有任何课程表现出大量的DE;16%显示中等水平,通常包括教师/同学照片,DEI陈述和专门的网页.
- 主动招聘策略,如无意识偏见培训或DEI统计数据显著缺失.
- 获得初始认证的课程的DE平均数量更高,尽管地理区域没有显示任何关联.
结论:
- 目前的REI奖学金网站很大程度上缺乏全面的多样性元素,这表明他们错过了招聘机会.
- 在计划网站上实施更广泛的DE可以显著提高招聘代表性不足的实习生.
- 专注于DEI内容的战略整合对于培养更多样化的REI员工来说至关重要.
相关概念视频
Infertility in Females
275
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
275
In Vitro Fertilization
213
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
213
Meiosis II
182.8K
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
182.8K
Infertility in Males
241
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
241
Fertilization
70.8K
During fertilization, an egg and sperm cell fuse to create a new diploid structure. In humans, the process occurs once the egg has been released from the ovary, and travels into the fallopian tubes. The process requires several key steps: 1) sperm present in the genital tract must locate the egg; 2) once there, sperm need to release enzymes to help them burrow through the protective zona pellucida of the egg; and 3) the membranes of a single sperm cell and egg must fuse, with the sperm...
70.8K
Embryonic Stem Cells
26.4K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
26.4K


